8-K: Y-mAbs Therapeutics Holds Annual Meeting, Elects Directors and Ratifies Auditor

Y-mAbs Therapeutics held its annual meeting on June 11, 2024, where shareholders elected three Class III directors, ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor, and approved executive compensation.

Summary

• Y-mAbs Therapeutics held its annual meeting of stockholders on June 11, 2024.
• A quorum was present at the meeting, allowing for the voting on three proposals.
• The first proposal was the election of three Class III directors: Michael Rossi, Thomas Gad, and Johan Wedell-Wedellsborg, each to serve until the 2027 annual meeting.
• Michael Rossi received 28,429,656 votes for, with 65,392 withheld and 3,466,788 broker non-votes.
• Thomas Gad received 21,845,733 votes for, with 6,649,315 withheld and 3,466,788 broker non-votes.
• Johan Wedell-Wedellsborg received 21,920,196 votes for, with 6,574,852 withheld and 3,466,788 broker non-votes.
• The second proposal was the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
• This proposal was approved with 31,959,182 votes for, 2,489 against, and 164 abstentions.
• The third proposal was a non-binding advisory vote on the compensation of the company's named executive officers.
• This proposal was approved with 27,772,834 votes for, 721,693 against, 521 abstentions, and 3,466,788 broker non-votes.

Sentiment

Score: 8

Explanation: The document reflects a routine corporate event with positive outcomes, indicating stability and adherence to governance practices.

Positives

• All three proposals presented at the annual meeting were approved by the stockholders.
• The election of directors ensures continuity in the company's leadership.
• The ratification of the independent auditor provides confidence in the company's financial reporting.
• The approval of executive compensation indicates shareholder support for the company's management.

Management Comments

• Michael Rossi, President and Chief Executive Officer, signed the report on behalf of the company.

Industry Context

This is a standard annual meeting procedure for a publicly traded company, ensuring corporate governance and accountability to shareholders.

Comparison to Industry Standards

• The election of directors and ratification of auditors are standard practices for publicly traded companies like Y-mAbs.
• The voting results are typical for such meetings, with the majority of votes cast in favor of the proposals.
• The use of a Big Four accounting firm like PricewaterhouseCoopers is common among companies of this size and complexity.

Management Changes

Stakeholder Impact

• Shareholders have successfully exercised their voting rights.
• The election of directors ensures continued leadership and strategic direction for the company.
• The ratification of the auditor provides assurance of financial integrity.
• The approval of executive compensation reflects shareholder confidence in management.

Key Dates

Keywords

Annual Meeting, Directors, PricewaterhouseCoopers, Executive Compensation, Shareholders, Voting, Auditor, Corporate Governance